It is not approved by the FDA or EMA for any clinical indication, and its legal status within most countries places it in the research-use category
LRRK2 Regulates CPT1A to Promote -Oxidation in HepG2 Cells
Disruptions to intestinal permeability, commonly called "leaky gut," have been implicated in the development of multiple autoimmune conditions including rheumatoid arthritis, type 1 diabetes, multiple sclerosis, and inflammatory bowel disease
However, its important to note that the usage of Wegovy should always be under the supervision of a healthcare professional
Some individuals with newly diagnosed celiac disease may be underweight due to malabsorption and may not be appropriate candidates for weight loss medications
It is illegal to sell Melanotan II in the US